These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23827936)

  • 21. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C; Davies G
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy.
    Tabarsi P; Moradi A; Baghaei P; Marjani M; Shamaei M; Mansouri N; Chitsaz E; Farnia P; Mansouri D; Masjedi M; Velayati A
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):547-50. PubMed ID: 21396217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of drug-resistant tuberculosis.
    Chiang CY; Schaaf HS
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin.
    Pinon M; Scolfaro C; Bignamini E; Cordola G; Esposito I; Milano R; Mignone F; Bertaina C; Tovo PA
    Pediatrics; 2010 Nov; 126(5):e1253-6. PubMed ID: 20974784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-resistant tuberculosis: controversies and challenges in pediatrics.
    Smith KC; Seaworth BJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):995-1010. PubMed ID: 16307511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.
    Schaaf HS; Marais BJ
    Paediatr Respir Rev; 2011 Mar; 12(1):31-8. PubMed ID: 21172673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-resistant tuberculosis: pediatric guidelines.
    Al-Dabbagh M; Lapphra K; McGloin R; Inrig K; Schaaf HS; Marais BJ; Sauve L; Kitai I; Kollmann TR
    Pediatr Infect Dis J; 2011 Jun; 30(6):501-5. PubMed ID: 21297522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy for tuberculosis; yesterday, today, and tomorrow--basic and clinical studies].
    Aoyagi T
    Kekkaku; 1998 Jul; 73(7):459-70. PubMed ID: 9739578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.